Business Context and Reporting Period
Company: Healthpeak Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 23, 2026
Event: Entry into material definitive agreements regarding credit facilities concurrent with the initial public offering (IPO) of Janus Living, Inc.
Key Financial Metrics and Debt Structure
This filing details amendments to existing credit agreements and the establishment of new borrowing capacity. No revenue, profit, or cash flow metrics are provided in this specific filing.
- New Facility: Established an Incremental Delayed Draw Term Loan (DDTL) Facility with aggregate principal commitments of $400.0 million.
- Maturity: The new Incremental DDTL Facility has a stated maturity of five years.
- Interest Rates:
- Base Rate Loans: Applicable margin ranges from 0.00% to 0.55% (initially 0.00% based on current ratings).
- SOFR Loans (Term or Daily): Applicable margin ranges from 0.70% to 1.55% (initially 0.80% based on current ratings).
- Floors: 1.00% for Base Rate; 0.00% for SOFR.
- Total Capacity Increase: Maximum aggregate borrowing capacity under the Healthpeak Term Loan Credit Agreement increased from $1.5 billion to $2.0 billion.
- Unused Capacity: As of the Closing Date, unused borrowing capacity under the Healthpeak Term Loan Credit Agreement was $750.0 million (including the new $400.0 million DDTL commitments).
Material Changes Versus Prior Period
The filing reports the following material changes to the company's debt structure effective March 23, 2026:
- Healthpeak Term Loan Amendment: Increased total borrowing capacity by $500 million (from $1.5 billion to $2.0 billion) and added the $400 million Incremental DDTL Facility.
- Revolving Credit Agreement Amendment: No changes to maturity date, pricing, or commitment amounts.
- Physicians Realty Term Loan Amendment: No changes to maturity date, pricing, or outstanding term loan amounts.
- Consent: Lenders provided consent for the Janus Living IPO and related transactions.
Guidance, Outlook, and Risks
Management Commentary: The amendments were executed to support the Janus Living IPO and provide additional liquidity flexibility. The company may incur additional incremental term loans up to the available capacity, subject to syndication on a best-efforts basis and the absence of defaults.
Risks and Contingencies:
- The new facility is subject to affirmative and negative covenants, including financial and reporting covenants.
- Additional incremental term loans are not guaranteed; no lender is required to increase their commitment to facilitate such incurrence.
- Interest rates are variable and subject to market fluctuations (SOFR and Base Rate).
Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the specific terms of the "Incremental DDTL Facility" in Exhibit 10.1 (Amendment No. 5 to Term Loan Agreement).
- Confirm the impact of the Janus Living IPO on Healthpeak's consolidated financial statements in subsequent filings.
- Review the specific financial covenants attached to the amended credit agreements to assess compliance risks.
- Monitor the utilization of the $750.0 million unused borrowing capacity.